- Home
- CARR vs TAK Comparison
CARR vs TAK Comparison
Compare CARR & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CARR | TAK |
|---|---|---|
| Founded | 2019 | 1781 |
| Country | United States | Japan |
| Employees | N/A | 47455 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4B | 56.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CARR | TAK |
|---|---|---|
| Price | $55.91 | $18.19 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $72.09 | N/A |
| AVG Volume (30 Days) | ★ 5.1M | 2.3M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | 1.72% | ★ 2.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | ★ $21,747,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.36 | $0.92 |
| P/E Ratio | ★ $32.47 | $41.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $50.24 | $12.99 |
| 52 Week High | $81.09 | $18.82 |
Technical Indicators
Market Signals| Indicator | CARR | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 34.12 | 54.85 |
| Support Level | $54.98 | $17.51 |
| Resistance Level | $61.55 | $18.82 |
| Average True Range (ATR) | 1.72 | 0.24 |
| MACD | -0.91 | -0.12 |
| Stochastic Oscillator | 7.23 | 53.52 |
Price Performance
Historical ComparisonAbout CARR Carrier Global Corporation
Carrier Global, spun out of United Technologies in 2020, manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its flagship Carrier brand, as well as Bryant, Payne, Heil, and others across various price points. In 2024, Carrier acquired Viessmann Climate Solutions to expand its footprint in Europe with heat pumps, boilers, and solar PV equipment. Proceeds from the sale of Carrier's fire and security (Honeywell) and commercial refrigeration (Haier) businesses reduced debt and focused the company on global HVAC and refrigeration solutions. Carrier generates 75% of sales from equipment and 25% from parts and services. The company derives 50% of revenue from the US, 30% from Europe, and 20% from the Asia-Pacific region.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.